These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7378140)

  • 21. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
    Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
    J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal therapy of the advanced breast cancer ].
    Gürtler R; Matthes ML; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
    Leake RE; Laing L; Calman KC; Macbeth FR; Crawford D; Smith DC
    Br J Cancer; 1981 Jan; 43(1):59-66. PubMed ID: 7459239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine therapy for advanced breast cancer: a review.
    Muss HB
    Breast Cancer Res Treat; 1992; 21(1):15-26. PubMed ID: 1382723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer.
    Rubens RD; Hayward JL
    Cancer; 1980 Dec; 46(12 Suppl):2922-4. PubMed ID: 7448737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapy.
    De Lena M; Brambilla C; Jirillo A
    Tumori; 1980 Jun; 66(3):339-48. PubMed ID: 7445113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.
    Paridaens R; Sylvester RJ; Ferrazzi E; Legros N; Leclercq G; Heuson JC
    Cancer; 1980 Dec; 46(12 Suppl):2889-95. PubMed ID: 7448734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Breast cancer and estrogen receptors: its clinical significance and problems].
    Izuo M
    Gan No Rinsho; 1983 Jun; 29(7):755-64. PubMed ID: 6348346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A relationship between artifical menopause, previous estrogen consumption, and estrogen receptor content of breast neoplasms: preliminary communication.
    Wallace RB; Sherman BM; Bean JA
    Oncology; 1980; 37(2):111-3. PubMed ID: 7360478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer.
    Maass H; Jonat W; Stolzenbach G; Trams G
    Cancer; 1980 Dec; 46(12 Suppl):2835-7. PubMed ID: 7470229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
    Mouridsen HT; Palshof T; Rose C
    Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational approaches to the hormonal treatment of breast cancer.
    Allegra JC
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):25-8. PubMed ID: 6669986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor in breast cancer of the Japanese.
    Nomura Y
    Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of aminoglutethimide for the treatment of advanced breast cancer. Clinical correlations with previous treatment, oestrogen-receptor and menstrual status.
    Bezwoda WR; Dansey RD; Hesdorffer CS; Browde S
    S Afr Med J; 1987 Jul; 72(2):107-9. PubMed ID: 3616780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid hormone receptors in the management of human breast cancer.
    Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
    Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.